Serological tests for antibodies specific for Epstein-Barr virus(EBV)antigens are frequently used to define infection status and for the differential diagnosis of other pathogens responsible for mononucleosis syndrome.Using only three parameters[viral capsid antigen(VCA)IgG,VCA IgM and EBV nuclear antigen(EBNA)-1 IgG],it is normally possible to distinguish acute from past infection:the presence of VCA IgM and VCA IgG without EBNA-1 IgG indicates acute infection,whereas the presence of VCA IgG and EBNA-1 IgG without VCA IgM is typical of past infection.However,serological findings may sometimes be difficult to interpret as VCA IgG can be present without VCA IgM or EBNA-1 IgG in cases of acute or past infection,or all the three parameters may be detected simultaneously in the case of recent infection or during the course of reactivation.A profile of isolated EBNA-1 IgG may also create some doubts.In order to interpret these patterns correctly,it is necessary to determine IgG avidity,identify anti-EBV IgG and IgM antibodies by immunoblotting,and look for heterophile antibodies,anti-EA(D)antibodies or viral genome using molecular biology methods.These tests make it possible to define the status of the infection and solve any problems that may arise in routine laboratory practice.